SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony LA Fields, MD, FRCPC
Cross Cancer Institute at University of Alberta
Study Chair - Michael J. O'Connell, MD
Mayo Clinic
Study Chair - Robert J. Mayer, MD, FACP
Dana-Farber Cancer Institute
Study Chair - Stephen R. Smalley, MD
University of Kansas
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saskatchewan Cancer Agency
Regina, Saskatchewan, Canada
- Pretoria Academic Hospital
Pretoria, South Africa
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (lakeside)
Chicago, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Siouxland Hematology-Oncology
Sioux City, Iowa, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Quain & Ramstad Clinic, P.C.
Bismarck, North Dakota, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Altru Health Systems
Grand Forks, North Dakota, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Ccop - Toledo Community Hospital Oncology Program
Toledo, Ohio, United States
- Ccop - Geisinger Clinical and Medical Center
Danville, Pennsylvania, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
- Ccop - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Veterans Affairs Medical Center - Milwaukee (zablocki)
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 1994
- Primary completion
- 31 Aug 2006
- Completion
- 31 Oct 2008
- Last update posted
- 5 Apr 2013
- Registered enrollment
- 1,917
- Registry id
- NCT00002551
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.